Cargando…

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

BACKGROUND: A simple, rapid and accurate stability-indicating reverse phase high performance liquid chromatography (RP-HPLC) was developed and validated for the determination of brimonidine tartrate in brimonidine tartrate/poly(2-hydroxyethyl methacrylate) (BRI/PHEMA) drug delivery contact lenses an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jianguo, Zhang, Xiuwen, Huang, Taomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505891/ https://www.ncbi.nlm.nih.gov/pubmed/29086854 http://dx.doi.org/10.1186/s13065-017-0292-2

Ejemplares similares

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System
por: Prabhu, P, et al.
Publicado: (2010)

Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013)

The role of brimonidine tartrate gel in the treatment of rosacea
por: Jackson, J Mark, et al.
Publicado: (2015)

Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
por: Zhao, Yujin, et al.
Publicado: (2022)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
por: Xu, Haonan, et al.
Publicado: (2023)

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use
por: Moshirfar, Majid, et al.
Publicado: (2023)

Stress Degradation Studies on Varenicline Tartrate and Development of a Validated Stability-Indicating HPLC Method
por: Pujeri, Sudhakar S., et al.
Publicado: (2012)

A validated stability-indicating HPLC method for the simultaneous determination of pheniramine maleate and naphazoline hydrochloride in pharmaceutical formulations
por: Huang, Taomin, et al.
Publicado: (2014)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
por: Alonso, Ruiz Simonato, et al.
Publicado: (2020)

Use of brimonidine tartrate to resolve telangiectatic matting: case report
por: de Mello, Brenno Augusto Seabra, et al.
Publicado: (2020)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
por: Kasuya, Yuka, et al.
Publicado: (2020)

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes
por: Abdel Azim, Engy A, et al.
Publicado: (2022)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
por: Emad Eldeeb, Alaa, et al.
Publicado: (2019)

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults
por: Nejad, Mitra, et al.
Publicado: (2021)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
por: Johnson, Andrew William, et al.
Publicado: (2015)

Loose-fit polypseudorotaxanes constructed from γ-CDs and PHEMA-PPG-PEG-PPG-PHEMA
por: Kong, Tao, et al.
Publicado: (2014)

Stability Indicating HPLC Determination of Risperidone in Bulk Drug and Pharmaceutical Formulations
por: Dedania, Zarna R., et al.
Publicado: (2011)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

Evaluation of stability and biocompatibility of PHEMA-PMMA keratoprosthesis by penetrating keratoplasty in rabbits
por: Hwang, Yawon, et al.
Publicado: (2016)

Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide
por: Sai Pavan Kumar, B., et al.
Publicado: (2013)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura, Toyoaki, et al.
Publicado: (2014)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
por: Azarcon, Corrina P., et al.
Publicado: (2020)

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation
por: Salim, Samar A., et al.
Publicado: (2023)

A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium
por: Huda, Naz Hasan, et al.
Publicado: (2018)

pHEMA: An Overview for Biomedical Applications
por: Zare, Mina, et al.
Publicado: (2021)

Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
por: Lee, Dasom, et al.
Publicado: (2016)

Stability-Indicating HPLC Determination of Trandolapril in Bulk Drug and Pharmaceutical Dosage Forms
por: Al-Hawash, Leena A., et al.
Publicado: (2015)

A validated stability-indicating HPLC method for determination of varenicline in its bulk and tablets
por: Kadi, Adnan A, et al.
Publicado: (2011)

Validation of a Stability-Indicating RP-HPLC Method for Determination of l-Carnitine in Tablets
por: Khoshkam, Roghaieh, et al.
Publicado: (2014)

Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam
por: Darwish, Hany W., et al.
Publicado: (2021)

Stability-Indicating HPLC Method for the Determination of Cefcapene Pivoxil
por: Zalewski, Przemysław, et al.
Publicado: (2012)

Stability-Indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations
por: Singh, Rahul, et al.
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
por: Kim, Ko Eun, et al.
Publicado: (2023)

Development and Validation of Stability Indicating RP-HPLC Method for Voriconazole
por: Khetre, A. B., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7rv7thp76c8lqdgnq0tp9cl0h3